Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06384976
Status:
RECRUITING
Last Update Posted:
2024-04-25
First Post:
2023-11-21
Brief Title:
KYSA-7 A Study of Anti-CD19 CAR T-Cell Therapy in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
Sponsor:
Kyverna Therapeutics
Organization:
Kyverna Therapeutics
Organization Data
Organization:
Kyverna Therapeutics
Class:
INDUSTRY
Study ID:
KYV101-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kyverna Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None